CASI Pharmaceuticals, Inc. (CASIF)
0.1288
-0.01
(-7.20%)
USD |
OTCM |
Aug 25, 16:00
CASI Pharmaceuticals EPS Diluted (Quarterly) : -0.6345 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | -0.6345 |
| September 30, 2025 | -0.6781 |
| June 30, 2025 | -0.8626 |
| March 31, 2025 | -0.6939 |
| December 31, 2024 | -0.9275 |
| September 30, 2024 | -0.5489 |
| June 30, 2024 | -0.5152 |
| March 31, 2024 | -0.712 |
| December 31, 2023 | -0.4467 |
| September 30, 2023 | -0.3465 |
| June 30, 2023 | -0.7673 |
| March 31, 2023 | -0.4505 |
| December 31, 2022 | -1.452 |
| September 30, 2022 | -0.3822 |
| June 30, 2022 | -0.5644 |
| March 31, 2022 | -0.6231 |
| December 31, 2021 | -0.4007 |
| September 30, 2021 | -0.7313 |
| June 30, 2021 | -0.4969 |
| March 31, 2021 | -1.112 |
| December 31, 2020 | -1.154 |
| September 30, 2020 | -1.437 |
| June 30, 2020 | -0.8615 |
| March 31, 2020 | -0.8546 |
| December 31, 2019 | -1.319 |
| Date | Value |
|---|---|
| September 30, 2019 | -1.032 |
| June 30, 2019 | -1.616 |
| March 31, 2019 | -0.8549 |
| December 31, 2018 | -0.9809 |
| September 30, 2018 | -1.007 |
| June 30, 2018 | -0.6811 |
| March 31, 2018 | -0.5042 |
| December 31, 2017 | -0.80 |
| September 30, 2017 | -0.30 |
| June 30, 2017 | -0.40 |
| March 31, 2017 | -0.30 |
| December 31, 2016 | -0.50 |
| September 30, 2016 | -0.30 |
| June 30, 2016 | -0.80 |
| March 31, 2016 | -0.40 |
| December 31, 2015 | -0.50 |
| September 30, 2015 | -0.50 |
| June 30, 2015 | -0.60 |
| March 31, 2015 | -0.60 |
| December 31, 2014 | -0.50 |
| September 30, 2014 | -7.70 |
| June 30, 2014 | -0.60 |
| March 31, 2014 | -0.50 |
| December 31, 2013 | -0.4839 |
| September 30, 2013 | -0.50 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.04M |
| Revenue (Quarterly) | 7.222M |
| Total Expenses (Quarterly) | 20.26M |
| Enterprise Value | 24.50M |
| Gross Profit Margin (Quarterly) | 51.14% |
| Profit Margin (Quarterly) | -180.6% |
| Earnings Yield | -2.23K% |
| Normalized Earnings Yield | -2221.27 |